CEVA Analyst Ratings
CEVA Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 32% | Barclays | $32 → $29 | Maintains | Overweight |
| 08/10/2023 | 36.55% | Northland Capital Markets | $35 → $30 | Maintains | Outperform |
| 08/10/2023 | -8.97% | Roth MKM | $30 → $20 | Downgrades | Buy → Neutral |
| 08/10/2023 | 59.31% | Rosenblatt | $45 → $35 | Maintains | Buy |
| 08/10/2023 | 32% | Barclays | $32 → $29 | Maintains | Overweight |
| 05/11/2023 | 59.31% | Oppenheimer | $40 → $35 | Maintains | Outperform |
| 05/11/2023 | 36.55% | Roth MKM | $40 → $30 | Maintains | Buy |
| 05/11/2023 | 36.55% | TD Cowen | $40 → $30 | Maintains | Outperform |
| 05/11/2023 | 45.65% | Barclays | $41 → $32 | Maintains | Overweight |
| 02/17/2023 | 86.62% | Barclays | $35 → $41 | Maintains | Overweight |
| 02/16/2023 | 82.07% | Cowen & Co. | $30 → $40 | Maintains | Outperform |
| 02/16/2023 | 104.82% | Rosenblatt | → $45 | Reiterates | → Buy |
| 02/14/2023 | 104.82% | Rosenblatt | → $45 | Reiterates | → Buy |
| 11/11/2022 | 59.31% | Barclays | $49 → $35 | Maintains | Overweight |
| 11/10/2022 | 104.82% | Rosenblatt | $60 → $45 | Maintains | Buy |
| 02/16/2022 | 173.1% | Rosenblatt | $50 → $60 | Upgrades | Neutral → Buy |
| 06/23/2021 | 127.58% | Rosenblatt | → $50 | Initiates Coverage On | → Neutral |
| 05/11/2021 | 154.89% | Barclays | $64 → $56 | Upgrades | Equal-Weight → Overweight |
| 05/11/2021 | 164% | Northland Capital Markets | $78 → $58 | Upgrades | Market Perform → Outperform |
| 02/17/2021 | 355.17% | Roth Capital | $60 → $100 | Maintains | Buy |
| 09/21/2020 | 118.48% | Northland Capital Markets | $37 → $48 | Upgrades | Market Perform → Outperform |
| 03/30/2020 | — | Northland Capital Markets | Upgrades | Market Perform → Outperform | |
| 08/09/2019 | 59.31% | Canaccord Genuity | $30 → $35 | Maintains | Buy |
| 04/17/2019 | — | Exane BNP Paribas | Downgrades | Outperform → Neutral | |
| 02/14/2019 | — | Northland Capital Markets | Downgrades | Outperform → Market Perform | |
| 10/16/2018 | 82.07% | Canaccord Genuity | $36 → $40 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月11日 | 32% | 巴克莱 | $32→$29 | 维护 | 超重 |
| 2023年08月10日 | 36.55% | 北国资本市场 | $35→$30 | 维护 | 跑赢大盘 |
| 2023年08月10日 | -8.97% | 罗斯MKM | $30→$20 | 评级下调 | 购买→中性 |
| 2023年08月10日 | 59.31% | 罗森布拉特 | $45→$35 | 维护 | 买 |
| 2023年08月10日 | 32% | 巴克莱 | $32→$29 | 维护 | 超重 |
| 2023年05月11日 | 59.31% | 奥本海默 | $40→$35 | 维护 | 跑赢大盘 |
| 2023年05月11日 | 36.55% | 罗斯MKM | $40→$30 | 维护 | 买 |
| 2023年05月11日 | 36.55% | TD Cowen | $40→$30 | 维护 | 跑赢大盘 |
| 2023年05月11日 | 45.65% | 巴克莱 | $41→$32 | 维护 | 超重 |
| 02/17/2023 | 86.62% | 巴克莱 | $35→$41 | 维护 | 超重 |
| 02/16/2023 | 82.07% | 考恩公司 | $30→$40 | 维护 | 跑赢大盘 |
| 02/16/2023 | 104.82% | 罗森布拉特 | →$45 | 重申 | →购买 |
| 02/14/2023 | 104.82% | 罗森布拉特 | →$45 | 重申 | →购买 |
| 2022年11月11日 | 59.31% | 巴克莱 | $49→$35 | 维护 | 超重 |
| 2022年11月10日 | 104.82% | 罗森布拉特 | $60→$45 | 维护 | 买 |
| 02/16/2022 | 173.1% | 罗森布拉特 | $50→$60 | 升级 | 中性→购买 |
| 2021/06/23 | 127.58% | 罗森布拉特 | →$50 | 开始承保 | →中性 |
| 2021/11/05 | 154.89% | 巴克莱 | $64→$56 | 升级 | 等重→超重 |
| 2021/11/05 | 164% | 北国资本市场 | $78→$58 | 升级 | 市场表现优于→ |
| 02/17/2021 | 355.17% | 罗斯资本 | $60→$100 | 维护 | 买 |
| 2020/09/21 | 118.48% | 北国资本市场 | $37→$48 | 升级 | 市场表现优于→ |
| 03/30/2020 | - | 北国资本市场 | 升级 | 市场表现优于→ | |
| 2019年08月09日 | 59.31% | 卡纳科特·格纳奇 | $30→$35 | 维护 | 买 |
| 2019/04/17 | - | 法国巴黎银行 | 评级下调 | 跑赢→中性 | |
| 2019年02月14日 | - | 北国资本市场 | 评级下调 | 跑赢→市场表现 | |
| 2018年10月16日 | 82.07% | 卡纳科特·格纳奇 | $36→$40 | 维护 | 买 |
What is the target price for CEVA (CEVA)?
CEVA(CEVA)的目标价是多少？
The latest price target for CEVA (NASDAQ: CEVA) was reported by Barclays on August 11, 2023. The analyst firm set a price target for $29.00 expecting CEVA to rise to within 12 months (a possible 32.00% upside). 15 analyst firms have reported ratings in the last year.
巴克莱银行于2023年8月11日报道了中国东方汇理银行(纳斯达克股票代码：CEVA)的最新目标价。这家分析公司将目标价定为29.00美元，预计CEVA将在12个月内升至(可能上涨32.00%)。过去一年，有15家分析公司公布了评级。
What is the most recent analyst rating for CEVA (CEVA)?
CEVA(CEVA)的最新分析师评级是多少？
The latest analyst rating for CEVA (NASDAQ: CEVA) was provided by Barclays, and CEVA maintained their overweight rating.
摩根大通(纳斯达克代码：CEVA)的最新分析师评级由巴克莱提供，CEVA维持其增持评级。
When is the next analyst rating going to be posted or updated for CEVA (CEVA)?
CEVA(CEVA)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CEVA, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CEVA was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与CEVA的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。CEVA的上一次评级是在2023年8月11日提交的，所以你应该预计下一次评级将在2024年8月11日左右提供。
Is the Analyst Rating CEVA (CEVA) correct?
分析师评级CEVA(CEVA)正确吗？
While ratings are subjective and will change, the latest CEVA (CEVA) rating was a maintained with a price target of $32.00 to $29.00. The current price CEVA (CEVA) is trading at is $21.97, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的CEVA评级维持不变，目标价在32.00美元至29.00美元之间。目前CEVA(CEVA)的交易价格为21.97美元，超出了分析师的预测区间。